- Report
- October 2019
- 159 Pages
Asia Pacific
From €2018EUR$2,100USD£1,735GBP
€2883EUR$3,000USD£2,479GBP
- Report
- October 2019
- 163 Pages
Europe
From €2018EUR$2,100USD£1,735GBP
€2883EUR$3,000USD£2,479GBP
- Report
- October 2019
- 134 Pages
North America
From €2018EUR$2,100USD£1,735GBP
€2883EUR$3,000USD£2,479GBP
- Report
- March 2019
- 162 Pages
Global
From €3060EUR$3,185USD£2,631GBP
€4372EUR$4,550USD£3,759GBP
- Report
- February 2024
- 93 Pages
Global
From €3500EUR$3,902USD£3,115GBP
- Report
- June 2023
- 132 Pages
Global
From €913EUR$950USD£785GBP
- Report
- July 2021
- 243 Pages
Global
From €3567EUR$3,712USD£3,067GBP
The Oligonucleotide Synthesis market is a segment of the biotechnology industry that focuses on the production of short, single-stranded DNA or RNA molecules. These molecules are used in a variety of applications, such as gene therapy, drug discovery, and diagnostics. Oligonucleotides are synthesized using a variety of techniques, including phosphoramidite chemistry, phosphorothioate chemistry, and solid-phase synthesis.
The Oligonucleotide Synthesis market is driven by the increasing demand for gene therapy and personalized medicine. Additionally, the development of new technologies, such as next-generation sequencing, has enabled the production of more complex oligonucleotides.
Some of the major players in the Oligonucleotide Synthesis market include Thermo Fisher Scientific, Agilent Technologies, Merck KGaA, Eurofins Scientific, and Bio-Synthesis. Show Less Read more